Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

p53-dependent downregulation of metastasis-associated laminin receptor

Abstract

Based on observations suggesting a role for the tumor suppressor protein p53 in regulating expression of the 67-kDa laminin receptor precursor, 37LRP, we analysed the 37LRP promoter activity in a wild-type p53 (wt p53) ovarian carcinoma cell line and in a cisplatin-resistant subline with mutated p53. We observed an increased promoter activity in wt p53 cells as compared to the mutated-p53 line when the first intron of the 37LRP gene was present in the reporter construct. Cotransfection experiments showed that the promoter is downregulated by both wt and mutated p53. Deletion analysis of the first intron localized an enhancer activity in the first 5′ 214 bp that upregulates both 37LRP and SV40 promoter activity and is repressed by both wt and mutant p53. Cotransfection, mutagenesis and gel-shift experiments identified a functional AP-2 cis-acting element in this intron region that is repressed by increased levels of both wt and mutated p53. Coimmunoprecipitation studies revealed AP-2 in physical association in vivo with both wt and mutated p53, indicating for the first time that interaction of p53 with AP-2 is involved in the repression mechanism and in the regulation of genes involved in cancer growth and progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Agoff SN, Hou J, Linzer DIH, Wu B . 1993 Science 259: 84–87

  • Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K . 1987 Current Protocols in Molecular Biology. John Wiley & Sons (ed) New York: Green Publishing Associated and Wiley-Interscience pp 2.1.1–2.1.2

    Google Scholar 

  • Baker SJ, Markowitz S, Fearon ER, Willson JKV, Vogelstein B . 1990 Science 249: 912–915

  • Bates NP, Hurst HC . 1997 Oncogene 15: 473–481

  • Borellini F, Glazer RI . 1993 J. Biol. Chem. 268: 7923–7928

  • Butò S, Tagliabue E, Aiello P, Ardini E, Magnifico A, Montuori N, Sobel ME, Colnaghi MI, Ménard S . 1997 Int. J. Biol. Markers 12: 1–5

  • Butò S, Tagliabue E, Ardini E, Magnifico A, Ghirelli C, van den Brûle F, Castronovo V, Colnaghi MI, Sobel ME, Ménard S . 1998 J. Cell Biochem. 69: 244–251

  • Castronovo V, Sobel ME . 1990 Biochem. Biophys. Res. Commun. 68: 1110–1117

  • Clausse N, Van den Brule F, Delvenne P, Jacobs N, Franzen-Detrooz E, Jackers P, Castronovo V . 1998 Biochem. Biophys. Res. Commun. 251: 564–569

  • Di Leo A, Bajetta E, Biganzoli L, Bohm S, Fabbiani M, Gebbia V, Lupi G, Mariani L, Ménard S, Oriana S, Ottone F, Pilotti S, Riboldi G, Sava C, Spatti G, Zunino F, di Re F . 1995 Eur. J. Cancer 31A: 2248–2254

  • Foley J, Wysolmerski JJ, Broadus AE, Philbrick WM . 1996 Cancer Res. 56: 4056–4062

  • Ginsberg D, Mechta F, Yaniv M, Oren M . 1991 Proc. Natl. Acad. Sci. USA 88: 9979–9983

  • Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC . 1994 Nucleic Acids Res. 22: 3551–3555

  • Iotsova V, Stehelin D . 1996 Cell Growth Differ. 7: 629–634

  • Jackers P, Minoletti F, Belotti D, Clausse N, Sozzi G, Sobel ME, Castronovo V . 1996 Oncogene 13: 495–503

  • Ko LJ, Prives C . 1996 Genes Dev. 10: 1054–1072

  • Landowski TH, Dratz EA, Starkey JR . 1995 Biochemistry 34: 11276–11287

  • Levine AJ . 1997 Cell 88: 323–331

  • Loging WT, Reisman D . 1999 Oncogene 18: 7608–7615

  • Marchuk D, Drumm M, Saulino A, Collins FS . 1991 Nucleic Acids Res. 19: 1154

  • Martignone S, Pellegrini R, Villa E, Tandon NN, Mastroianni A, Tagliabue E, Ménard S, Colnaghi MI . 1992 Clin. Exp. Met. 10: 379–386

  • McPherson LA, Weigel RJ . 1999 Nucleic Acids Res. 27: 4040–4049

  • Ménard S, Castronovo V, Tagliabue E, Sobel ME . 1997 J. Cell Biochem. 67: 155–165

  • Ménard S, Tagliabue E, Colnaghi MI . 1998 Breast Cancer Res. Treat. 52: 137–145

  • Nadji M, Nassiri M, Fresno M, Terzian E, Morales AR . 1999 Cancer 85: 432–436

  • Pal S, Datta K, Mukhopadhyay D . 2001 Cancer Res. 61: 6952–6957

  • Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F . 1996 Cancer Res. 56: 556–562

  • Perissi V, Menini N, Cottone E, Capello D, Sacco M, Montaldo F, De Bortoli M . 2000 Oncogene 19: 280–288

  • Perrem K, Rayner J, Voss T, Sturzbecher H, Jackson P, Braithwaite A . 1995 Oncogene 11: 1299–1307

  • Raghunath P, Sidhu GS, Coon HC, Liu K, Srikantan V, Maheshwari RK . 1993 J. Biol. Regul. Homeost. Agents 7: 22–30

  • Rao CN, Castronovo V, Schmitt MC, Wewer UM, Claysmith AP, Liotta LA, Sobel ME . 1989 Biochemistry 28: 7476–7486

  • Righetti SC, Della Torre G, Pilotti S, Ménard S, Ottone F, Colnaghi MI, Pierotti MA, Lavarino C, Cornarotti M, Oriana S, Böhm S, Bresciani GL, Spatti G, Zunino F . 1996 Cancer Res. 56: 689–693

  • Santhanam U, Ray A, Sehgal PB . 1991 Proc. Natl. Acad. Sci. USA 88: 7605–7609

  • Subler MA, Martin DW, Deb S . 1992 J. Virol. 66: 4757–4762

  • Wigler M, Pellicer A, Silverstein S, Axel R . 1978 Cell 14: 725–731

  • Yao KS, Godwin AK, Johnson SW, Oxols RF, O'Dwyer PJ, Hamilton TC . 1995 Cancer Res. 55: 4367–4374

  • Zeng YX, Somasundaram K, El-Deiry WS . 1997 Nat. Genet. 15: 78–82

Download references

Acknowledgements

We thank Dr Fabio Castiglioni for help with figures, Mrs Piera Aiello and Mrs Cristina Ghirelli for excellent technical assistance, and Mrs Laura Mameli for manuscript preparation. This work was supported by grants from AIRC. Michele Modugno was supported by a fellowship from FIRC.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sylvie Ménard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Modugno, M., Tagliabue, E., Ardini, E. et al. p53-dependent downregulation of metastasis-associated laminin receptor. Oncogene 21, 7478–7487 (2002). https://doi.org/10.1038/sj.onc.1205957

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205957

Keywords

This article is cited by

Search

Quick links